Pathstone Family Office, LLC Amgen Inc Transaction History

Pathstone Family Office, LLC

$15.6 Billion
Q3 2023

A detailed history of Pathstone Family Office, LLC transactions in Amgen Inc stock. As of the latest transaction made, Pathstone Family Office, LLC holds 49,135 shares of AMGN stock, worth $13 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

49,135

Previous 12,788 284.23%

Holding current value

$13 Million

Previous $2.84 Million 365.13%

% of portfolio

0.08%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $7.95 Million - $9.87 Million	36,347 Added 284.23%	49,135 $13.2 Million
Q2 2023 Jan 12, 2024	SELL	$214.27 - $253.37 $7.65 Million - $9.05 Million	-35,717 Reduced 72.69%	13,418 $2.98 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $274,265 - $324,313	1,280 Added 11.12%	12,788 $2.84 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $2.6 Million - $3.16 Million	-11,497 Reduced 49.98%	11,508 $2.78 Million
Q4 2022 Oct 23, 2023	BUY	$229.03 - $291.01 $2.69 Million - $3.41 Million	11,734 Added 104.11%	23,005 $6.04 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $436,073 - $554,083	1,904 Added 9.02%	23,005 $6.04 Million
Q3 2022 Oct 23, 2023	BUY	$224.46 - $253.15 $1.42 Million - $1.61 Million	6,344 Added 128.76%	11,271 $2.54 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $1.61 Million - $1.82 Million	7,180 Added 51.58%	21,101 $5.29 Million
Q2 2022 Oct 23, 2023	SELL	$230.71 - $256.74 $1.81 Million - $2.02 Million	-7,861 Reduced 61.47%	4,927 $1.2 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $2.83 Million - $3.15 Million	12,273 Added 744.72%	13,921 $3.39 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $49,993 - $55,305	-228 Reduced 12.15%	1,648 $980,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $127,680 - $146,119	-642 Reduced 25.5%	1,876 $425,000
Q3 2021 Nov 16, 2021	SELL	$212.27 - $248.7 $377,203 - $441,939	-1,777 Reduced 41.37%	2,518 $536,000
Q2 2021 Aug 31, 2021	BUY	$233.58 - $259.14 $146,454 - $162,480	627 Added 17.09%	4,295 $1.05 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $308,676 - $359,712	-1,391 Reduced 27.5%	3,668 $913,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $81,575 - $97,141	377 Added 8.05%	5,059 $1.16 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $20,414 - $22,702	87 Added 1.89%	4,682 $1.19 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $185,347 - $227,447	-937 Reduced 16.94%	4,595 $1.09 Million
Q1 2020 Jun 11, 2020	BUY	$182.24 - $241.7 $991,750 - $1.32 Million	5,442 Added 6046.67%	5,532 $1.12 Million
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $833,019 - $1.1 Million	-4,571 Reduced 98.07%	90 $18.2 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $3,405 - $4,377	-18 Reduced 0.38%	4,661 $11.2 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $792,026 - $949,012	-4,549 Reduced 49.3%	4,679 $906,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $105,687 - $123,889	634 Added 7.38%	9,228 $1.7 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $1.55 Million - $1.75 Million	8,594 New	8,594 $1.63 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $22,914 - $25,738	-138 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $23,381 - $27,324	138 New	138 $24,000
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $301,122 - $343,800	-1,800 Closed	0 $0
Q2 2017 Aug 16, 2017	BUY	N/A	1,800	1,800 $310,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Account

Pathstone Family Office, LLC Amgen Inc Transaction History